Matteo Molica

Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment

Massimo Breccia, Matteo Molica, Irene Zacheo et al. · Annals of Hematology · 2014 · 63 citations

Hematological Malignancy, Cardiovascular Epidemiology, Cardiovascular Disease +12

Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)

Salvatore Giacomo Morano, Roberto Latagliata, Corrado Girmenia et al. · Supportive Care in Cancer · 2015 · 53 citations

Inserted Central Catheters, Thrombosis, Venous Disease +7

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival

Massimo Breccia, Luigiana Luciano, Roberto Latagliata et al. · Leukemia Research · 2014 · 34 citations

Hematological Malignancy, Concomitant Comorbidities, Aging +10

Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL)

Stefano Molica, Giovanna Digiesi, Anna Antenucci et al. · Leukemia Research · 2011 · 29 citations

Hematological Malignancy, Vitamin D Insufficiency, Medicine +6

Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia

Stefano Molica, Giovanna Cutrona, Gaetano Vitelli et al. · Leukemia Research · 2007 · 29 citations

Hematological Malignancy, Increased Angiogenesis, Lymphoid Neoplasia +13